Cargando…
Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin
Ovarian, head and neck, and other cancers are commonly treated with cisplatin and other DNA damaging cytotoxic agents. Altered DNA damage response (DDR) contributes to resistance of these tumors to chemotherapies, some targeted therapies, and radiation. DDR involves multiple protein complexes and si...
Autores principales: | Gaponova, Anna V., Deneka, Alexander Y., Beck, Tim N., Liu, Hanqing, Andrianov, Gregory, Nikonova, Anna S., Nicolas, Emmanuelle, Einarson, Margret B., Golemis, Erica A., Serebriiskii, Ilya G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386675/ https://www.ncbi.nlm.nih.gov/pubmed/27863405 http://dx.doi.org/10.18632/oncotarget.13353 |
Ejemplares similares
-
Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization
por: Ramirez, Ursula D., et al.
Publicado: (2015) -
Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model
por: Deneka, Alexander Y., et al.
Publicado: (2017) -
Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer
por: Deneka, Alexander Y., et al.
Publicado: (2020) -
Microscopy-Based Automated Live Cell Screening for Small Molecules That Affect Ciliation
por: Zhang, Peishan, et al.
Publicado: (2019) -
NEDD9 sustains hexokinase expression to promote glycolysis
por: Deneka, Alexander Y., et al.
Publicado: (2022)